HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients

Several human leukocyte antigen (HLA) alleles are strongly associated with susceptibility to classic Hodgkin lymphoma (cHL), also in subgroups stratified for presence of the Epstein–Barr virus (EBV). We tested the hypothesis that the pressure on cHL tumour cells to lose HLA expression is associated...

Full description

Bibliographic Details
Main Authors: Geok Wee Tan, Peijia Jiang, Ilja M. Nolte, Kushi Kushekhar, Rianne N. Veenstra, Bouke G. Hepkema, Ruth F. Jarrett, Anke van den Berg, Arjan Diepstra
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/22/5833
_version_ 1797510940682354688
author Geok Wee Tan
Peijia Jiang
Ilja M. Nolte
Kushi Kushekhar
Rianne N. Veenstra
Bouke G. Hepkema
Ruth F. Jarrett
Anke van den Berg
Arjan Diepstra
author_facet Geok Wee Tan
Peijia Jiang
Ilja M. Nolte
Kushi Kushekhar
Rianne N. Veenstra
Bouke G. Hepkema
Ruth F. Jarrett
Anke van den Berg
Arjan Diepstra
author_sort Geok Wee Tan
collection DOAJ
description Several human leukocyte antigen (HLA) alleles are strongly associated with susceptibility to classic Hodgkin lymphoma (cHL), also in subgroups stratified for presence of the Epstein–Barr virus (EBV). We tested the hypothesis that the pressure on cHL tumour cells to lose HLA expression is associated with HLA susceptibility alleles. A meta-analysis was carried out to identify consistent protective and risk HLA alleles in a combined cohort of 839 cHL patients from the Netherlands and the United Kingdom. Tumour cell HLA expression was studied in 338 cHL cases from these two cohorts and correlated to the presence of specific susceptibility HLA alleles. Carriers of the HLA-DRB1*07 protective allele frequently lost HLA class II expression in cHL overall. Patients carrying the HLA-DRB1*15/16 (DR2) risk allele retained HLA class II expression in EBV− cHL and patients with the HLA-B*37 risk allele retained HLA class I expression more frequently than non-carriers in EBV+ cHL. The other susceptibility alleles showed no significant differences in expression. Thus, HLA expression by tumour cells is associated with a subset of the protective and risk alleles. This strongly suggests that HLA associations in cHL are related to peptide binding capacities of specific HLA alleles.
first_indexed 2024-03-10T05:38:20Z
format Article
id doaj.art-71a4121273e74fb4b2f653f84a47405b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T05:38:20Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-71a4121273e74fb4b2f653f84a47405b2023-11-22T22:43:58ZengMDPI AGCancers2072-66942021-11-011322583310.3390/cancers13225833HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma PatientsGeok Wee Tan0Peijia Jiang1Ilja M. Nolte2Kushi Kushekhar3Rianne N. Veenstra4Bouke G. Hepkema5Ruth F. Jarrett6Anke van den Berg7Arjan Diepstra8Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Laboratory Medicine, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UKDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The NetherlandsSeveral human leukocyte antigen (HLA) alleles are strongly associated with susceptibility to classic Hodgkin lymphoma (cHL), also in subgroups stratified for presence of the Epstein–Barr virus (EBV). We tested the hypothesis that the pressure on cHL tumour cells to lose HLA expression is associated with HLA susceptibility alleles. A meta-analysis was carried out to identify consistent protective and risk HLA alleles in a combined cohort of 839 cHL patients from the Netherlands and the United Kingdom. Tumour cell HLA expression was studied in 338 cHL cases from these two cohorts and correlated to the presence of specific susceptibility HLA alleles. Carriers of the HLA-DRB1*07 protective allele frequently lost HLA class II expression in cHL overall. Patients carrying the HLA-DRB1*15/16 (DR2) risk allele retained HLA class II expression in EBV− cHL and patients with the HLA-B*37 risk allele retained HLA class I expression more frequently than non-carriers in EBV+ cHL. The other susceptibility alleles showed no significant differences in expression. Thus, HLA expression by tumour cells is associated with a subset of the protective and risk alleles. This strongly suggests that HLA associations in cHL are related to peptide binding capacities of specific HLA alleles.https://www.mdpi.com/2072-6694/13/22/5833cHLsusceptibilityHLA expressionEBV
spellingShingle Geok Wee Tan
Peijia Jiang
Ilja M. Nolte
Kushi Kushekhar
Rianne N. Veenstra
Bouke G. Hepkema
Ruth F. Jarrett
Anke van den Berg
Arjan Diepstra
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
Cancers
cHL
susceptibility
HLA expression
EBV
title HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
title_full HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
title_fullStr HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
title_full_unstemmed HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
title_short HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
title_sort hla expression in relation to hla type in classic hodgkin lymphoma patients
topic cHL
susceptibility
HLA expression
EBV
url https://www.mdpi.com/2072-6694/13/22/5833
work_keys_str_mv AT geokweetan hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT peijiajiang hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT iljamnolte hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT kushikushekhar hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT riannenveenstra hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT boukeghepkema hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT ruthfjarrett hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT ankevandenberg hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients
AT arjandiepstra hlaexpressioninrelationtohlatypeinclassichodgkinlymphomapatients